Clinical Efficacy of Picosecond Laser Therapy for Melasma
Study Overview
This study evaluated how effective picosecond laser therapy combined with the Shumin Star is for treating melasma. It also looked at how skin barrier function indicators can help assess treatment progress.
Study Details
Ninety patients with melasma were divided into two groups:
- Study Group: Received both picosecond laser therapy and Shumin Star.
- Control Group: Received only picosecond laser therapy.
Key Findings
- The study group had a higher clinical efficacy rate (95.56%) compared to the control group (82.22%).
- After 3 months, the study group showed significant improvements in skin barrier function, including:
- Trans-epidermal water loss (TEWL)
- Stratum corneum hydration
- Sebum content
- The study group also had a lower total MASI score, indicating better melasma treatment outcomes.
- Fewer adverse reactions were reported in the study group compared to the control group.
Conclusion
Combining picosecond laser therapy with the Shumin Star is effective for treating melasma. Monitoring skin barrier function can help assess treatment success, providing valuable insights for clinical use.
Enhancing Clinical Practice with AI
Clinical trials are essential for developing safe and effective treatments. To bring these benefits into everyday practice, our AI-driven platform, DocSym, consolidates ICD-11 standards, clinical protocols, and research into one easy-to-use resource for healthcare providers.
Streamlining Operations
In today’s healthcare landscape, efficiency is key. Our mobile apps assist with:
- Scheduling appointments
- Monitoring treatments
- Telemedicine services
This makes managing patient care easier and expands digital services.
Improving Patient Outcomes
By utilizing AI, clinics can enhance workflows, improve patient outcomes, and reduce reliance on paper processes. Discover how we can assist you at aidevmd.com.
